DK77787A - Fremgangsmaade til fremstilling af en makromolekylaer baerer ladet med et biologisk aktivt stof - Google Patents

Fremgangsmaade til fremstilling af en makromolekylaer baerer ladet med et biologisk aktivt stof

Info

Publication number
DK77787A
DK77787A DK077787A DK77787A DK77787A DK 77787 A DK77787 A DK 77787A DK 077787 A DK077787 A DK 077787A DK 77787 A DK77787 A DK 77787A DK 77787 A DK77787 A DK 77787A
Authority
DK
Denmark
Prior art keywords
ldl
active substance
biologically active
lyophilised
dissolved
Prior art date
Application number
DK077787A
Other languages
English (en)
Other versions
DK77787D0 (da
DK168785B1 (da
Inventor
Michele Masquelier
Curt Peterson
Mikael Ros
Mats Rudling
Sigurd Vitols
Original Assignee
Oncholab Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncholab Ab filed Critical Oncholab Ab
Publication of DK77787D0 publication Critical patent/DK77787D0/da
Publication of DK77787A publication Critical patent/DK77787A/da
Application granted granted Critical
Publication of DK168785B1 publication Critical patent/DK168785B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK077787A 1985-06-17 1987-02-16 Fremgangsmåde til fremstilling af en bærer ladet med lipofilt biologisk aktivt stof på basis af rekonstitueret LDL DK168785B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8502998 1985-06-17
SE8502998A SE456136B (sv) 1985-06-17 1985-06-17 Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
PCT/SE1986/000291 WO1986007540A1 (en) 1985-06-17 1986-06-17 Method for the preparation of a macromolecular carrier loaded with a biologically active substance, product thus obtained and use thereof
SE8600291 1986-06-17

Publications (3)

Publication Number Publication Date
DK77787D0 DK77787D0 (da) 1987-02-16
DK77787A true DK77787A (da) 1987-02-16
DK168785B1 DK168785B1 (da) 1994-06-13

Family

ID=20360603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK077787A DK168785B1 (da) 1985-06-17 1987-02-16 Fremgangsmåde til fremstilling af en bærer ladet med lipofilt biologisk aktivt stof på basis af rekonstitueret LDL

Country Status (11)

Country Link
US (1) US4868158A (da)
EP (1) EP0229100B1 (da)
JP (1) JPS62502549A (da)
AT (1) ATE67412T1 (da)
AU (1) AU583402B2 (da)
DE (1) DE3681578D1 (da)
DK (1) DK168785B1 (da)
FI (1) FI86802C (da)
NO (1) NO169048C (da)
SE (1) SE456136B (da)
WO (1) WO1986007540A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609399A1 (fr) * 1987-01-13 1988-07-15 Ire Celltarg Sa Procede d'incorporation d'un ou plusieurs principes actifs lipophiles dans des lipoproteines, lipoproteines obtenues et composition pharmaceutique les contenant
FR2664500B1 (fr) * 1990-07-13 1994-10-28 Lille Ii Universite Droit Sant Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant.
AU665599B2 (en) * 1991-11-08 1996-01-11 Hemosol Inc. Hemoglobins as drug delivery agents
CA2117749A1 (en) * 1992-04-08 1993-10-28 Paavo Kai Johannes Kinnunen Composition for therapeutic or diagnostic use, process for its preparation and its use
AU690592B2 (en) * 1993-11-08 1998-04-30 Peptide Delivery Systems Pty Ltd Labelled diagnostic compositions and methods of their use
EP0728019A4 (en) * 1993-11-08 1999-07-07 Peptide Delivery Systems Pty L MARKED DIAGNOSTIC COMPOSITIONS AND METHODS OF USE THEREOF
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
JP2001503735A (ja) * 1996-07-03 2001-03-21 ユニバーシティ オブ ピッツバーグ 親水性活性試薬のためのエマルジョン処方物
AUPP032097A0 (en) * 1997-11-11 1997-12-04 Peptide Delivery Systems Pty Ltd Improved labelled diagnostic compositions and methods of their use
US6514523B1 (en) 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
AU2021252164A1 (en) 2020-04-09 2022-12-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4356117A (en) * 1980-10-23 1982-10-26 U.S. Govt., Dept. Of Health & Human Services Chemical modifications of proteins which induce new receptor specificities and therefore elicit new effects in cells
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
NZ208241A (en) * 1984-05-22 1987-09-30 John Stephen Ayers Purification of blood plasma or serum: selective removal of (very) low density lipoproteins (ldl and vldl)
EP0238645A1 (en) * 1985-10-03 1987-09-30 Biotechnology Research Partners, Ltd. Novel lipoprotein-based drug-delivery systems

Also Published As

Publication number Publication date
NO169048C (no) 1992-05-06
NO870545D0 (no) 1987-02-11
SE8502998D0 (sv) 1985-06-17
FI870644A (fi) 1987-02-16
FI86802C (fi) 1992-10-26
AU5996886A (en) 1987-01-13
EP0229100B1 (en) 1991-09-18
US4868158A (en) 1989-09-19
ATE67412T1 (de) 1991-10-15
EP0229100A1 (en) 1987-07-22
DK77787D0 (da) 1987-02-16
WO1986007540A1 (en) 1986-12-31
DK168785B1 (da) 1994-06-13
FI86802B (fi) 1992-07-15
FI870644A0 (fi) 1987-02-16
NO870545L (no) 1987-02-11
JPH0586935B2 (da) 1993-12-14
AU583402B2 (en) 1989-04-27
JPS62502549A (ja) 1987-10-01
DE3681578D1 (de) 1991-10-24
SE8502998L (sv) 1986-12-18
SE456136B (sv) 1988-09-12
NO169048B (no) 1992-01-27

Similar Documents

Publication Publication Date Title
DK77787A (da) Fremgangsmaade til fremstilling af en makromolekylaer baerer ladet med et biologisk aktivt stof
Coore et al. Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones
KR830002327A (ko) 약학적 제제
EP0277459A3 (en) Sustained release drug
ES2070827T3 (es) Microcristales que contienen una sustancia activa que presenta afinidad por los fosfolipidos y al menos un fosfolipido, procedimiento de preparacion.
DK0652754T3 (da) Lægemidler til topisk påføring af kønssteroider til behandling af tørt øje-syndrom samt fremgangsmåder til fremstilling og påføring deraf
DK0627490T3 (da) Fremgangsmåde til fremstilling af langkædet inuli n
OA08170A (fr) Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues.
HUT54885A (en) Process for producing liofilized pharmaceutical compositions containing active components
Gottschalk Neuraminic acid: the functional group of some biologically active mucoproteins
Isherwood et al. Synthesis of l-ascorbic acid in rat-liver homogenates: conversion of l-gulono-and l-galactono-γ-lactone and the respective acids into l-ascorbic acid
Malakhova et al. New approach to the study of enzyme reactions with the participation of water-insoluble substrates. Pancreatic lipase incorporated into the inverted micelles of a surface-active substance in an organic solvent
Adams Studies on the mucin derived from human colloid breast carcinoma
Narurkar et al. Prodrugs of 5-iodo-2′-deoxyuridine for enhanced ocular transport
ZENSER et al. Effects of prostaglandins on hepatic adenylate cyclase activity and cyclic adenosine 3', 5',-monophosphate content
Badawy et al. Changes in liver tryptophan and tryptophan pyrrolase activity after administration of salicylate and tryptophan to the rat
KR860003825A (ko) 안정한 현탁액 제조용 고체 약물제형의 제조방법
Clark et al. Altered Distribution and Excretion of N 1-Methylnicotinamide in Rats with Walker 256 Carcinosarcoma
Ackerman et al. Solubilization of 3-hydroxy-3-methylglutaryl coenzyme A reductase from lyophilized rat liver microsomes: lack of evidence for cold lability in this soluble enzyme preparation
Kempen et al. Rat pancreatic adenylate cyclase: IV. Effect of hormones and other agents on cyclic AMP level and enzyme release
Pekas Naphthol metabolism: Glucuronide conjugation and transport by the rat intestine in vitro
ES2029466T3 (es) Un metodo para la preparacion de una composicion hidrofoba que contiene enzimas y la composicion producida a partir del mismo.
KR890701596A (ko) 알카로이드 추출
Vandenberg et al. Adenyl cyclase in the haemocytes of the American cockroach
Anez et al. Sugars in the alimentary canal of Lutzomyia youngi (Diptera: Phlebotominae)